• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从研究到常规诊断转变中的新方法

[New methods at the transition from research to routine diagnostics].

作者信息

Papantonis Argyris, Rogalla Stephan, Dullin Christian, Alves Frauke, Bohnenberger Hanibal

机构信息

Institut für Pathologie, Fachbereich Thorax- und Molekularpathologie, Universitätsmedizin Göttingen, Robert-Koch-Straße 40, 37075, Göttingen, Deutschland.

Abteilung für Gastroenterologie und Hepatologie, Medizinische Fakultät, Stanford University, Stanford, CA, USA.

出版信息

Pathologie (Heidelb). 2025 May;46(3):156-162. doi: 10.1007/s00292-024-01412-8. Epub 2025 Jan 22.

DOI:10.1007/s00292-024-01412-8
PMID:39841205
Abstract

BACKGROUND

Pathology, traditionally focused on classification and diagnosis, is continuously evolving through new technologies. Advances in proteomics, epigenetics, tissue staining, and 3D imaging expand the possibilities of classical morphology.

AIM OF THE STUDY

The aim of this study was to investigate how modern technologies can improve diagnostic accuracy and therapy selection and how they can be integrated into pathologic routine diagnostics.

MATERIALS AND METHODS

Recent studies in proteomics, epigenetics, multiplex tissue staining, and 3D tissue imaging were analyzed to assess their application and the challenges of clinical implementation.

RESULTS

The analysis shows significant potential for pathologic diagnostics. Proteomics provides a deeper understanding of the molecular architecture of tumors, while epigenetics and 3D genome architecture offer new insights into genetic regulation and tumor heterogeneity. Multiplex tissue staining and 3D tissue imaging improve spatial tissue analysis.

DISCUSSION

Despite the potential to improve diagnostics, high costs, technical complexity, and lack of standardization hinder integration into clinical practice. Nevertheless, these technologies offer promising approaches for optimizing diagnostics and therapy selection. Research and interdisciplinary collaboration are crucial to successfully integrating these innovations into routine clinical practice.

摘要

背景

病理学传统上专注于分类和诊断,正通过新技术不断发展。蛋白质组学、表观遗传学、组织染色和三维成像技术的进步拓展了经典形态学的可能性。

研究目的

本研究旨在探讨现代技术如何提高诊断准确性和治疗选择,以及如何将它们整合到病理常规诊断中。

材料与方法

分析蛋白质组学、表观遗传学、多重组织染色和三维组织成像方面的最新研究,以评估其应用及临床实施的挑战。

结果

分析表明病理诊断具有巨大潜力。蛋白质组学能更深入了解肿瘤的分子结构,而表观遗传学和三维基因组结构为基因调控和肿瘤异质性提供了新见解。多重组织染色和三维组织成像改善了空间组织分析。

讨论

尽管有改善诊断的潜力,但高成本、技术复杂性和缺乏标准化阻碍了其融入临床实践。然而,这些技术为优化诊断和治疗选择提供了有前景的方法。研究和跨学科合作对于将这些创新成功整合到常规临床实践中至关重要。

相似文献

1
[New methods at the transition from research to routine diagnostics].从研究到常规诊断转变中的新方法
Pathologie (Heidelb). 2025 May;46(3):156-162. doi: 10.1007/s00292-024-01412-8. Epub 2025 Jan 22.
2
A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance.2015年预测性分子病理学及其在靶向癌症治疗中的作用更新:聚焦临床相关性的综述
Cancer Gene Ther. 2015 Sep;22(9):417-30. doi: 10.1038/cgt.2015.39. Epub 2015 Sep 11.
3
Approaching clinical proteomics: current state and future fields of application in cellular proteomics.临床蛋白质组学方法学:细胞蛋白质组学中当前的应用领域和未来的发展方向。
Cytometry A. 2009 Oct;75(10):816-32. doi: 10.1002/cyto.a.20779.
4
Predictive pathology in routine diagnostics of solid tumors.实体瘤常规诊断中的预测病理学。
Histol Histopathol. 2012 Mar;27(3):289-96. doi: 10.14670/HH-27.289.
5
Introduction to progress and promise of epigenetics for diagnosis and therapy in cancer.癌症诊断与治疗中表观遗传学的进展与前景介绍
Cancer Genet. 2015 May;208(5):165-6. doi: 10.1016/j.cancergen.2015.04.003. Epub 2015 Apr 14.
6
Proteomic applications in pathology and laboratory medicine: Present state and future prospects.蛋白质组学在病理学和检验医学中的应用:现状与未来展望。
Clin Biochem. 2020 Aug;82:12-20. doi: 10.1016/j.clinbiochem.2020.05.007. Epub 2020 May 19.
7
Clinical proteomics: written in blood.临床蛋白质组学:书写在血液之中。
Nature. 2003 Oct 30;425(6961):905. doi: 10.1038/425905a.
8
Mass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspective.基于质谱的蛋白质组学分析作为肿瘤学诊断工具:现状与未来展望。
Clin Chem Lab Med. 2009;47(6):666-84. doi: 10.1515/CCLM.2009.159.
9
Multi-omics based artificial intelligence for cancer research.基于多组学的人工智能在癌症研究中的应用。
Adv Cancer Res. 2024;163:303-356. doi: 10.1016/bs.acr.2024.06.005. Epub 2024 Jul 9.
10
Proteomics in cancer research: Are we ready for clinical practice?癌症研究中的蛋白质组学:我们准备好应用于临床实践了吗?
Crit Rev Oncol Hematol. 2015 Dec;96(3):437-48. doi: 10.1016/j.critrevonc.2015.07.006. Epub 2015 Aug 12.

本文引用的文献

1
Symptom trajectories over time by cannabis use status among patients undergoing cancer treatment.癌症治疗患者中按大麻使用状况划分的随时间推移的症状轨迹。
Sci Rep. 2024 Nov 16;14(1):28319. doi: 10.1038/s41598-024-78501-4.
2
Clonal evolution of the 3D chromatin landscape in patients with relapsed pediatric B-cell acute lymphoblastic leukemia.复发性儿童 B 细胞急性淋巴细胞白血病患者三维染色质景观的克隆进化。
Nat Commun. 2024 Aug 28;15(1):7425. doi: 10.1038/s41467-024-51492-6.
3
Pervasive structural heterogeneity rewires glioblastoma chromosomes to sustain patient-specific transcriptional programs.
弥漫性结构异质性重塑胶质母细胞瘤染色体以维持患者特异性转录程序。
Nat Commun. 2024 May 9;15(1):3905. doi: 10.1038/s41467-024-48053-2.
4
Label-free quantification of imaging features in the extracellular matrix of left and right-sided colon cancer tissues.无标记定量分析左、右侧结肠癌组织细胞外基质的影像学特征。
Sci Rep. 2024 Mar 29;14(1):7510. doi: 10.1038/s41598-024-58231-3.
5
Invasive uses a unique processive wall teichoic acid glycosyltransferase to evade immune recognition.侵袭性利用独特的连续延伸壁磷壁酸糖基转移酶来逃避免疫识别。
Sci Adv. 2023 Nov 24;9(47):eadj2641. doi: 10.1126/sciadv.adj2641.
6
Tracing cancer evolution and heterogeneity using Hi-C.利用 Hi-C 技术追踪癌症进化和异质性。
Nat Commun. 2023 Nov 6;14(1):7111. doi: 10.1038/s41467-023-42651-2.
7
High-Load Gemcitabine Inorganic-Organic Hybrid Nanoparticles as an Image-Guided Tumor-Selective Drug-Delivery System to Treat Pancreatic Cancer.高载量吉西他滨无机-有机杂化纳米粒作为一种图像引导的肿瘤选择性药物传递系统治疗胰腺癌。
Adv Mater. 2023 Nov;35(46):e2305151. doi: 10.1002/adma.202305151. Epub 2023 Oct 5.
8
MALAT1 modulates alternative splicing by cooperating with the splicing factors PTBP1 and PSF.MALAT1 通过与剪接因子 PTBP1 和 PSF 合作来调节可变剪接。
Sci Adv. 2022 Dec 23;8(51):eabq7289. doi: 10.1126/sciadv.abq7289.
9
Structural variants drive context-dependent oncogene activation in cancer.结构变异驱动癌症中与上下文相关的癌基因激活。
Nature. 2022 Dec;612(7940):564-572. doi: 10.1038/s41586-022-05504-4. Epub 2022 Dec 7.
10
Immune cell topography predicts response to PD-1 blockade in cutaneous T cell lymphoma.免疫细胞图谱预测 PD-1 阻断治疗皮肤 T 细胞淋巴瘤的反应。
Nat Commun. 2021 Nov 18;12(1):6726. doi: 10.1038/s41467-021-26974-6.